A comprehensive analysis of six forms of cytochrome P450 2C (CYP2C) in pigs

References

• Achour B, Barber J, Rostami-Hodjegan A. 2011. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos. 39(11):2130–2134.
   PubMed Web of Science ®Google Scholar
• Barnes HJ, Arlotto MP, Waterman MR. 1991. Expression and enzymatic activity of recombinant cytochrome P450 17a-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A. 88(13):5597–5601.
   PubMed Web of Science ®Google Scholar
• Buyssens L, De Clerck L, Schelstraete W, Dhaenens M, Deforce D, Ayuso M, Van Ginneken C, Van Cruchten S. 2021. Hepatic cytochrome P450 abundance and activity in the developing and adult gottingen minipig: pivotal data for PBPK modeling. Front Pharmacol. 12:665644.
   PubMed Web of Science ®Google Scholar
• Goldstein JA. 2001. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 52(4):349–355.
   PubMed Web of Science ®Google Scholar
• Gotoh O. 1992. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem. 267(1):83–90.
   PubMed Web of Science ®Google Scholar
• Ibeanu GC, Ghanayem BI, Linko P, Li L, Pederson LG, Goldstein JA. 1996. Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity. J Biol Chem. 271(21):12496–12501.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. 2007. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther. 116(3):496–526.
   PubMed Web of Science ®Google Scholar
• Iwata H, Fujita K, Kushida H, Suzuki A, Konno Y, Nakamura K, Fujino A, Kamataki T. 1998. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem Pharmacol. 55(8):1315–1325.
   PubMed Web of Science ®Google Scholar
• Jung F, Griffin KJ, Song W, Richardson TH, Yang M, Johnson EF. 1998. Identification of amino acid substitutions that confer a high affinity for sulfaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19. Biochemistry. 37(46):16270–16279.
   PubMed Web of Science ®Google Scholar
• Kojima M, Degawa M. 2016. Sex differences in constitutive mRNA levels of CYP2B22, CYP2C33, CYP2C49, CYP3A22, CYP3A29 and CYP3A46 in the pig liver: comparison between Meishan and Landrace pigs. Drug Metab Pharmacokinet. 31(3):185–192.
   PubMed Web of Science ®Google Scholar
• Kojima M, Degawa M. 2021. Androgen-dependent differences in the amounts of CYP mRNAs in the pig kidney. Biol Pharm Bull. 44(8):1120–1128.
   PubMed Web of Science ®Google Scholar
• Kojima M, Morozumi T. 2004. Cloning of six full-length cDNAs encoding pig cytochrome P450 enzymes and gene expression of these enzymes in the liver and kidney. J Health Sci. 50(5):518–529.
   Web of Science ®Google Scholar
• Millecam J, De Clerck L, Govaert E, Devreese M, Gasthuys E, Schelstraete W, Deforce D, De Bock L, Van Bocxlaer J, Sys S, et al. 2018. The ontogeny of cytochrome P450 enzyme activity and protein abundance in conventional pigs in support of preclinical pediatric drug research. Front Pharmacol. 9:470.
   PubMed Web of Science ®Google Scholar
• Mogi M, Toda A, Iwasaki K, Kusumoto S, Takehara H, Shimizu M, Murayama N, Izumi H, Utoh M, Yamazaki H. 2012. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to microminipigs. J Toxicol Sci. 37(6):1157–1164.
   PubMed Web of Science ®Google Scholar
• Murayama N, Kaneko N, Horiuchi K, Ohyama K, Shimizu M, Ito K, Yamazaki H. 2009. Cytochrome P450-dependent drug oxidation activity of liver microsomes from microminipigs, a possible new animal model for humans in non-clinical studies. Drug Metab Pharmacokinet. 24(4):404–408.
   PubMed Web of Science ®Google Scholar
• Nakanishi K, Uehara S, Kusama T, Inoue T, Shimura K, Kamiya Y, Murayama N, Shimizu M, Uno Y, Sasaki E, et al. 2018. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants [3. Biochem Pharmacol. 152(6):272–278.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 14(1):1–18.
   PubMedGoogle Scholar
• Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. 2006. The human intestinal cytochrome P450 "pie". Drug Metab Dispos. 34(5):880–886.
   PubMed Web of Science ®Google Scholar
• Puccinelli E, Gervasi PG, La Marca M, Beffy P, Longo V. 2010. Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues. Xenobiotica. 40(8):525–535.
   PubMed Web of Science ®Google Scholar
• Puccinelli E, Gervasi PG, Longo V. 2011. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Curr Drug Metab. 12(6):507–525.
   PubMed Web of Science ®Google Scholar
• Schelstraete W, Clerck L, Govaert E, Millecam J, Devreese M, Deforce D, Bocxlaer JV, Croubels S. 2019. Characterization of porcine hepatic and intestinal drug metabolizing CYP450: comparison with human orthologues from a quantitative, activity and selectivity perspective. Sci Rep. 9(1):9233.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 270(1):414–423.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, Kawano M, Shimizu M, Toda A, Utoh M, Sasaki E, Yamazaki H. 2015. Novel marmoset cytochrome P450 2C19 in livers efficiently metabolizes human P450 2C9 and 2C19 substrates, S-warfarin, tolbutamide, flurbiprofen, and omeprazole. Drug Metab Dispos. 43(10):1408–1416.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, Kawano M, Shimizu M, Toda A, Utoh M, Sasaki E, Yamazaki H. 2016. Individual differences in metabolic clearance of s-warfarin efficiently mediated by polymorphic marmoset cytochrome P450 2C19 in livers. Drug Metab Dispos. 44(7):911–915.
   PubMed Web of Science ®Google Scholar
• Uno Y, Fujino H, Kito G, Kamataki T, Nagata R. 2006. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol. 70(2):477–486.
   PubMed Web of Science ®Google Scholar
• Uno Y, Shimizu M, Ogawa Y, Makiguchi M, Kawaguchi H, Yamato O, Ishizuka M, Yamazaki H. 2022. Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats. Biochem Pharmacol. 202:115125.
   PubMed Web of Science ®Google Scholar
• Wiercinska P, Squires EJ. 2010. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5. Drug Metab Dispos. 38(5):857–862.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, et al. 2002. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif. 24(3):329–337.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Shimizu M, Uno Y, Yamazaki H. 2014. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs. Biochem Pharmacol. 90(2):159–165.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141.
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos PG, Skantz A, Eliasson M, Ahlberg MB. 1995. Cytochrome P450 genes expressed in porcine ovaries: identification of novel forms, evidence for gene conversion, and evolutionary relationships. Biochem Biophys Res Commun. 212(2):433–441.
   PubMed Web of Science ®Google Scholar